1) Wagner JC, Sleggs CA, Marchand P:Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 17:260-271, 1960
2) Selikoff IJ, Churg J, Hammond EC:Asbestos exposure and neoplasia. JAMA 188:22-26, 1964
3) Bianchi C, Bianchi T:Malignant mesothelioma:global incidence and relationship with asbestos. Ind Health 45:379-387, 2007
4) 厚生労働省ホームページ 〈http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/tokusyu/chuuhisyu06/index.html〉
5) Anonymous. Asbestos, asbestosis, and cancer:the Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health 23:311-316, 1997
6) 国立がんセンターホームページ 〈http://ganjoho.ncc.go.jp/public/statistics/backnumber/odjrh3000000o8is-att/FIG22.PDF〉
7) World Health Organization:Elimination of asbestos-related diseases, 2006 〈http://www.who.int/occupational_health/publications/asbestosrelateddisease/en/index.html〉
8) Nishikawa K, Takahashi K, Karjalainen A, et al:Recent mortality from mesothelioma, historical patterns of asbestos use and adoption of bans:a global assessment, submitted and under review.
9) 高橋謙:石綿ばく露と石綿関連疾患の国際比較疫学.最新医学 62:27-34,2007
10) Lin RT, Takahashi K, Karjalainen A, et al:Ecological association between asbestos-related diseases and historical asbestos consumption:an international analysis. Lancet 369:844-849, 2007
11) Peto J, Hodgson JT, Mathews FE, et al:Continuing increase in mesothelioma mortality in Britain. Lancet 345:535-539, 1995
12) Weill H, Hughes JM, Churg AM:Changing trends in US mesothelioma incidence. Occup Environ Med 61:438-441, 2004
13) Kjaergarrd J, Andersson M:Incidence rates of malignant mesothelioma in Denmark and predicted future number of cases among men. Scand J Work Environ Health 26:112-117, 2000
14) Burdorf A, Jarvholm B, Englund A:Explaining differences in incidence rates of pleural mesothelioma between Sweden and the Netherlands. Int J Cancer 113:298-301, 2005
15) Marinaccio A, Montanaro F, Mastrantonio M, et al:Predictions of mortality from pleural mesothelioma in Italy:a model based on asbestos consumption figures supports results from age-period-cohort models. Int J Cancer 115:142-147, 2005
16) Segura O, Burdorf A, Looman C:Update of predictions of mortality from pleural mesothelioma in the Netherlands. Occup Environ Med 60:50-55, 2003
17) Price B:Analysis of current trends in United States mesothelioma incidence. Am J Epidemiol 145:211-218, 1997
18) Price B, Ware A:Mesothelioma trends in the United States:an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol 159:107-112, 2004
19) NIOSH(National Institute for Occupational Safety and Health):Work-Related Lung Disease(WoRLD)Surveillance System:Malignant Mesothelioma. 〈http://www2a.cdc.gov/drds/WorldReportData/SectionDetails.asp?SectionTitleID=7〉
20) Montanaro F, Bray F, Gennaro V, et al:Pleural mesothelioma incidence in Europe:evidence of some deceleration in the increasing trends. Cancer Causes Control 14:791-803, 2003